Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Krämer

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Endocrinological Investigation|June 19, 2008
Pharmacy and pharmacology of biosimilarsI Krämer
Arzneimittel-Forschung|July 1, 1986
[Synthesis and H2-antagonistic action of N3, N5-substituted 1,2, 4-oxadiazole-3, 5-diamine. 26. H2-antihistaminics]I Krämer, W Schunack
Pharmacy World & Science : PWS|July 31, 1999
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containersJ Thiesen, I Krämer
Arzneimittel-Forschung|November 1, 1986
[Synthesis and H2-antagonistic action of N,N-substituted 1,3,4-oxadiazole-2,5-diamine. 30. H2-antihistaminics]I Krämer, W Schunack
Die Pharmazie|October 31, 2006
[Stability of busulfan injection solution (Busilvex, Busulfex) in B/Braun Injekt syringes]A Karstens, I Krämer
MMW Fortschritte Der Medizin|November 9, 2012
[The dilemma of discharge medication. A multicentre cohort study on distribution of discharge medication and counseling by the hospital pharmacist in comparison to current practice]C Mildner, I Krämer
International Journal of Molecular Sciences|November 6, 2019
How Epigenetic Modifications Drive the Expression and Mediate the Action of PGC-1α in the Regulation of MetabolismAnne I Krämer, Christoph Handschin
Herzschrittmachertherapie & Elektrophysiologie|September 14, 2010
[Curriculum and expert courses on pacemaker and ICD therapy]L-I Krämer, R Griebenow
Journal of Clinical Pharmacy and Therapeutics|February 9, 2007
Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancerI Krämer, H-P Lipp
Transplantation Proceedings|June 4, 2013
Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimenM Eberlin, G Otto, I Krämer
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Endocrinological Investigation|June 19, 2008
Pharmacy and pharmacology of biosimilarsI Krämer
Arzneimittel-Forschung|July 1, 1986
[Synthesis and H2-antagonistic action of N3, N5-substituted 1,2, 4-oxadiazole-3, 5-diamine. 26. H2-antihistaminics]I Krämer, W Schunack
Pharmacy World & Science : PWS|July 31, 1999
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containersJ Thiesen, I Krämer
Arzneimittel-Forschung|November 1, 1986
[Synthesis and H2-antagonistic action of N,N-substituted 1,3,4-oxadiazole-2,5-diamine. 30. H2-antihistaminics]I Krämer, W Schunack
Die Pharmazie|October 31, 2006
[Stability of busulfan injection solution (Busilvex, Busulfex) in B/Braun Injekt syringes]A Karstens, I Krämer
MMW Fortschritte Der Medizin|November 9, 2012
[The dilemma of discharge medication. A multicentre cohort study on distribution of discharge medication and counseling by the hospital pharmacist in comparison to current practice]C Mildner, I Krämer
International Journal of Molecular Sciences|November 6, 2019
How Epigenetic Modifications Drive the Expression and Mediate the Action of PGC-1α in the Regulation of MetabolismAnne I Krämer, Christoph Handschin
Herzschrittmachertherapie & Elektrophysiologie|September 14, 2010
[Curriculum and expert courses on pacemaker and ICD therapy]L-I Krämer, R Griebenow
Journal of Clinical Pharmacy and Therapeutics|February 9, 2007
Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancerI Krämer, H-P Lipp
Transplantation Proceedings|June 4, 2013
Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimenM Eberlin, G Otto, I Krämer
Pageof 3